These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

279 related items for PubMed ID: 15129579

  • 1. [Risk of thromboembolism in contraception and hormone substitution: an update and recommendations].
    van den Brûle F, Gaspard U.
    J Pharm Belg; 2004; 59(1):38-40. PubMed ID: 15129579
    [Abstract] [Full Text] [Related]

  • 2. [Oral contraception and menopausal hormone replacement: effects on hemostasis and risk of venous thromboembolism].
    Bounameaux H, de Moerloose P, Campana A.
    Schweiz Med Wochenschr; 1996 Oct 12; 126(41):1756-63. PubMed ID: 8966508
    [Abstract] [Full Text] [Related]

  • 3. [Hormone therapy and cardiovascular risk].
    Wütschert R, Cirafici P.
    Praxis (Bern 1994); 2000 Jun 29; 89(25-26):1090-7. PubMed ID: 11367591
    [Abstract] [Full Text] [Related]

  • 4. Risk of venous thromboembolic disease associated with hormonal contraceptives and hormone replacement therapy: a clinical review.
    Gomes MP, Deitcher SR.
    Arch Intern Med; 2004 Oct 11; 164(18):1965-76. PubMed ID: 15477430
    [Abstract] [Full Text] [Related]

  • 5. Hormones and pregnancy: thromboembolic risks for women.
    Kujovich JL.
    Br J Haematol; 2004 Aug 11; 126(4):443-54. PubMed ID: 15287937
    [Abstract] [Full Text] [Related]

  • 6. [Venous and arterial thrombotic events induced by synthetic-steroid hormones or oral contraceptives].
    Sugawara H, Kawakami M.
    Nihon Rinsho; 1999 Jul 11; 57(7):1657-64. PubMed ID: 10429474
    [Abstract] [Full Text] [Related]

  • 7. Hormones and cardiovascular health in women.
    ESHRE Capri Workshop Group.
    Hum Reprod Update; 2006 Jul 11; 12(5):483-97. PubMed ID: 16807276
    [Abstract] [Full Text] [Related]

  • 8. [Hormonal contraception and postmenopausal estrogen substitution in relation to malignant tumors].
    Lauritzen C.
    Zentralbl Gynakol; 1990 Jul 11; 112(17):1071-90. PubMed ID: 2264417
    [Abstract] [Full Text] [Related]

  • 9. [Effect of hormonal changes in women on hemostasis].
    Malý J, Dulícek P.
    Vnitr Lek; 2002 Dec 11; 48(12):1169-73. PubMed ID: 12642936
    [Abstract] [Full Text] [Related]

  • 10. Hormone therapy and thromboembolic disease.
    Battaglioli T, Martinelli I.
    Curr Opin Hematol; 2007 Sep 11; 14(5):488-93. PubMed ID: 17934355
    [Abstract] [Full Text] [Related]

  • 11. [Pregnancy, contraception and HRT and venous thromboembolism].
    Conard J, Gompel A.
    Rev Prat; 2007 Apr 15; 57(7):759-66. PubMed ID: 17626321
    [Abstract] [Full Text] [Related]

  • 12. [Postmenopausal hormonal substitution and risk of venous thromboembolism. Need for prospective, randomized trials].
    Arnesen H, Qvigstad E.
    Tidsskr Nor Laegeforen; 1997 Nov 20; 117(28):4064. PubMed ID: 9441436
    [No Abstract] [Full Text] [Related]

  • 13. [Heavy legs, venous insufficiency of the legs and hormone substitution therapy].
    Haesler E, Hayoz D.
    Praxis (Bern 1994); 2000 Jun 29; 89(25-26):1098-104. PubMed ID: 11367592
    [Abstract] [Full Text] [Related]

  • 14. Oral contraception and thrombophilia.
    Blickstein D, Blickstein I.
    Curr Opin Obstet Gynecol; 2007 Aug 29; 19(4):370-6. PubMed ID: 17625421
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study.
    Canonico M, Oger E, Plu-Bureau G, Conard J, Meyer G, Lévesque H, Trillot N, Barrellier MT, Wahl D, Emmerich J, Scarabin PY, Estrogen and Thromboembolism Risk (ESTHER) Study Group.
    Circulation; 2007 Feb 20; 115(7):840-5. PubMed ID: 17309934
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Family history and risk of venous thromboembolism with oral contraception. Family history is important tool.
    Vandenbroucke JP, van der M eer FJ, Helmerhorst FM, Rosendaal FR.
    BMJ; 2001 Sep 29; 323(7315):752. PubMed ID: 11675729
    [No Abstract] [Full Text] [Related]

  • 19. [The use of hormonal contraception in perimenopause is still a hazard?].
    Buttarelli M, Ghezzi F, Cromi A, Raio L, Franchi M.
    Minerva Ginecol; 2001 Dec 29; 53(6):421-9. PubMed ID: 11723427
    [Abstract] [Full Text] [Related]

  • 20. Oral contraceptives and hormonal replacement therapy cause an imbalance in coagulation and fibrinolysis which may explain the increased risk of venous thromboembolism.
    Levi M, Middeldorp S, Büller HR.
    Cardiovasc Res; 1999 Jan 29; 41(1):21-4. PubMed ID: 10325950
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.